
About KRM Ayurveda
KRM Ayurveda is a publicly listed company based in Delhi (India) founded in 1937. KRM Ayurveda offers comprehensive consultancy services in yoga, diet, and medications for holistic well-being. It operates on a B2C model. The company has 131 employees. Its Indian entity Krm Ayurveda Limited reported revenue of ₹102 Cr. Its focus areas include Health and Wellness, Alternative Medicine, Consultancy Services and Ayurveda and Yoga.
Company details
KRM Ayurveda, founded in 1937 in Delhi, India, focuses on promoting health and well-being, alternative medicine, consultancy services, and ayurveda and yoga. KRM Ayurveda offers comprehensive consultancy services in yoga, diet, and medications for holistic well-being. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Delhi, India
- Employees 131
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website krmayurveda.com
- Social Facebook
- Legal Name Krm Ayurveda Limited
- Date of Incorporation 03 Sep, 2019
- Jurisdiction Delhi, India
- Market Cap₹502 Cr
KRMAYURVED-SM · NSE
- Share Price₹225.45
-4.47% today
- Revenue₹102 Cr
FY 2025-26 · +32.8% YoY
- EBITDA₹30.50 Cr
Margin 30.0%
- Net Profit₹20.13 Cr
FY 2025-26 · +66.5% YoY
- Latest Funding Round$454.19K (USD), Unspecified
Sep 2025
- InvestorsSaint Capital Fund
& 13 more
- Employee Count131
Associated legal entities of KRM Ayurveda
KRM Ayurveda operates through Krm Ayurveda Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Krm Ayurveda Limited Listed CIN U24239DL2019PLC354658 | Active | 03 Sep 2019 | Delhi, Delhi | ₹102 Cr | 131 | 6 | View details |
Funding Insights of KRM Ayurveda
- Total Rounds 1
- Last Round Unspecified — $454,192
- First Round $454,192
(Sep 2025)
- Investors Count 14
All 1 funding rounds of KRM Ayurveda with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $454,192 | Unspecified | – | Shyam Sunder |
14 investors in total: 1 institutional and 13 angel.
Investors in KRM Ayurveda
KRM Ayurveda has secured backing from 14 investors, including angel and venture fund investors. Prominent investors backing the company include Shyam Sunder, Sagar P Brahmbhatt and Nageshwarrao Srikrishna Duvvuri.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in multiple sectors | saintcapitalfund.com | Ebene City, Mauritius | ||
SS Shyam Sunder | unknown_758ef1db30544eec8 | |||
SP Sagar P Brahmbhatt | unknown_7c25e46e0f7c40baa | |||
NS Nageshwarrao Srikrishna Duvvuri | unknown_e05c689b16a1425d8 | |||
AJ Amit Jindal | unknown_b1aa4a7bf771466db | |||
UG Usha Gupta | unknown_fee50cbc195a4f03a | |||
KS Kajal Singla | unknown_e6d36ab95f49408eb | |||
SG Shirish Goel | unknown_f6b48fd90c9041e69 | |||
PB Pankaj Bansal | unknown_c5d92c0321584feb9 | |||
SA Shruti Aggarwal | unknown_eac5bf873bd340538 |
Investor details for KRM Ayurveda
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Krm Ayurveda Limited (KRM Ayurveda)
Krm Ayurveda Limited is the primary company behind KRM Ayurveda. The board of Krm Ayurveda Limited currently have 5 directors; the longest-serving is Puneet Dhawan, appointed in 2019. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Puneet Dhawan DIN 08553667 | Managing Director | 03 Sep 2019 | 7 yrs 1 mo | Krm Ayurveda Limited |
| Sanchit Hans DIN 09228549 | Whole-time director | 24 Feb 2023 | 3 yrs 8 mo | Krm Ayurveda Limited |
| Tanya Dhawan DIN 08553668 | Director | 30 Sep 2024 | 2 yrs 1 mo | Krm Ayurveda Limited |
| Vandana Gupta DIN 00013488 | Director | 21 Jan 2025 | 1 yr 9 mo | Krm Ayurveda Limited |
| Laxmi DIN 10717921 | Director | 21 Jan 2025 | 1 yr 9 mo | Krm Ayurveda Limited |
People of KRM Ayurveda
1 people are tracked at KRM Ayurveda (1 in leadership); the tracked headcount is 131.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for KRM Ayurveda
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of KRM Ayurveda
KRM Ayurveda is a publicly listed company on the NSE with ticker symbol KRMAYURVED in India. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: KRMAYURVED
- Listed entityKrm Ayurveda Limited
Financials of KRM Ayurveda
Exchange-reported figures of Krm Ayurveda Limited, the listed company behind KRM Ayurveda (NSE: KRMAYURVED-SM).
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 102 | 76.55 | 67.16 | 89.29 |
| Revenue growth | +32.8% | +14.0% | -24.8% | - |
| EBITDA | 30.50 | 19.47 | 7.62 | 11.18 |
| EBITDA margin | +30.0% | +25.4% | +11.4% | +12.5% |
| Profit before tax | 26.73 | 16.34 | 4.74 | 10.08 |
| Net profit | 20.13 | 12.09 | 3.43 | 7.59 |
| Net profit margin | +19.8% | +15.8% | +5.1% | +8.5% |
| EPS (₹) | 9.46 | 806.48 | 2,274.80 | 5,065.33 |
| Balance sheet | ||||
| Total assets | 115 | 55.78 | 35.34 | 28.47 |
| Net worth | 115 | 23.90 | 11.78 | 8.37 |
| Total debt | 0.00 | 31.20 | 23.18 | 19.87 |
| Cash & bank | 9.47 | 2.04 | 0.50 | 0.23 |
| Net working capital | 49.35 | 19.43 | 11.98 | 4.66 |
| Cash flow | ||||
| Cash from operations | 1.12 | 3.49 | (0.89) | 3.51 |
| Cash from investing | (30.50) | (7.85) | (0.13) | (22.94) |
| Cash from financing | 36.81 | 5.90 | 1.29 | 19.47 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 32.32 | 32.21 | 21.12 | 23.69 | 24.67 |
| Revenue growth (YoY) | +31.0% | - | - | - | - |
| Other income | 0.54 | 0.19 | 0.14 | 0.15 | 0.15 |
| Total expenses | 20.30 | 21.22 | 14.57 | 17.07 | 18.45 |
| EBITDA | 12.02 | 10.99 | 6.55 | 6.62 | 6.22 |
| EBITDA margin | +37.2% | +34.1% | +31.0% | +27.9% | +25.2% |
| Depreciation | 0.26 | 0.31 | 0.30 | 0.28 | 0.25 |
| Interest | 0.06 | 0.63 | 0.91 | 0.90 | 0.69 |
| Profit before tax | 12.24 | 10.24 | 5.48 | 5.59 | 5.43 |
| Tax | 3.15 | 2.42 | 1.40 | 1.49 | 1.37 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 32.32 | 32.21 | 21.12 | 23.69 | 24.67 |
| Revenue growth (YoY) | +31.0% | - | - | - | - |
| Other income | 0.54 | 0.19 | 0.14 | 0.15 | 0.15 |
| Total expenses | 20.30 | 21.22 | 14.57 | 17.07 | 18.45 |
| EBITDA | 12.02 | 10.99 | 6.55 | 6.62 | 6.22 |
| EBITDA margin | +37.2% | +34.1% | +31.0% | +27.9% | +25.2% |
| Depreciation | 0.26 | 0.31 | 0.30 | 0.28 | 0.25 |
| Interest | 0.06 | 0.63 | 0.91 | 0.90 | 0.69 |
| Profit before tax | 12.24 | 10.24 | 5.48 | 5.59 | 5.43 |
| Tax | 3.15 | 2.42 | 1.40 | 1.49 | 1.37 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Revenue | 102 | 76.55 | 67.16 | 89.29 |
| Revenue growth | +32.8% | +14.0% | -24.8% | - |
| Other income | 0.62 | 0.40 | 0.42 | 0.09 |
| Total expenses | 71.19 | 57.08 | 59.54 | 78.11 |
| Employee cost | 0.00 | 17.12 | 18.70 | 18.32 |
| EBITDA | 30.50 | 19.47 | 7.62 | 11.18 |
| EBITDA margin | +30.0% | +25.4% | +11.4% | +12.5% |
| Depreciation | 1.14 | 1.04 | 1.02 | 0.64 |
| Interest | 3.25 | 2.49 | 2.28 | 0.55 |
| Profit before tax | 26.73 | 16.34 | 4.74 | 10.08 |
| Tax | 6.60 | 4.25 | 1.31 | 2.49 |
| Net profit | 20.13 | 12.09 | 3.43 | 7.59 |
| Net profit margin | +19.8% | +15.8% | +5.1% | +8.5% |
| EPS (₹) | 9.46 | 806.48 | 2,274.80 | 5,065.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Equity & liabilities | ||||
| Share capital | 21.26 | 0.15 | 0.15 | 0.15 |
| Reserves & surplus | 93.45 | 23.75 | 11.63 | 8.22 |
| Shareholders' funds (net worth) | 115 | 23.90 | 11.78 | 8.37 |
| Secured loans | 0.00 | 31.20 | 23.18 | 19.42 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.45 |
| Total debt | 0.00 | 31.20 | 23.18 | 19.87 |
| Total liabilities | 115 | 55.78 | 35.34 | 28.47 |
| Assets | ||||
| Gross block | 30.88 | 29.97 | 25.24 | 24.71 |
| Net block | 26.33 | 26.56 | 22.87 | 23.36 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 38.30 | 8.80 | 0.00 | 0.00 |
| Inventories | 9.03 | 7.70 | 1.45 | 0.67 |
| Sundry debtors | 22.73 | 12.13 | 5.53 | 7.76 |
| Cash & bank balances | 9.47 | 2.04 | 0.50 | 0.23 |
| Loans & advances | 14.93 | 8.47 | 13.06 | 7.01 |
| Total current assets | 56.16 | 30.34 | 20.54 | 15.67 |
| Total current liabilities | 6.81 | 10.91 | 8.56 | 11.01 |
| Net working capital | 49.35 | 19.43 | 11.98 | 4.66 |
| Total assets | 115 | 55.78 | 35.34 | 28.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Opening cash | 2.04 | 0.50 | 0.23 | 0.71 |
| Net cash from operating activities | 1.12 | 3.49 | (0.89) | 3.51 |
| Net cash from investing activities | (30.50) | (7.85) | (0.13) | (22.94) |
| Net cash from financing activities | 36.81 | 5.90 | 1.29 | 19.47 |
| Net change in cash | 7.43 | 1.54 | 0.27 | 0.05 |
| Closing cash | 9.47 | 2.04 | 0.50 | 0.23 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | +32.8% | +14.0% | -24.8% | - |
| EBITDA growth | +56.7% | +155.5% | -31.8% | - |
| PBT growth | +63.6% | +244.7% | -53.0% | +9997.0% |
| Net income growth | +66.5% | +252.5% | -54.8% | - |
| Revenue CAGR (3Y) | +4.4% | - | - | - |
| EBITDA CAGR (3Y) | +39.7% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +19.8% | +15.8% | +5.1% | +8.5% |
| Return on capital employed | - | +41.3% | +21.9% | +37.4% |
| Return on net worth | - | +67.9% | +33.9% | +90.8% |
| Debt / equity | - | 1.52 | 2.14 | 2.37 |
| Long-term debt / equity | - | 1.10 | 1.89 | 2.11 |
| Interest cover | 11.07 | 13.51 | 34.55 | 5.22 |
| Efficiency & per share | ||||
| Fixed asset turnover | - | 2.77 | 2.69 | 3.61 |
| Inventory turnover | - | 16.73 | 63.36 | 133.27 |
| Debtors turnover | - | 8.67 | 10.11 | 11.51 |
| EPS (₹) | 9.46 | 806.48 | 2,274.80 | 5,065.33 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 1,591.72 | 7,852.33 | 5,577.53 |
Timeline of KRM Ayurveda
2 dated milestones of KRM Ayurveda across 88 years, from founding to its latest funding, stage changes and deals.
- Founded KRM Ayurveda is founded.
- Funding First funding round of $454K.
Top companies in Alternative Medicine Products
3 companies that operate in the same segment as KRM Ayurveda (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Homeopathic medicine manufacturing and online retail in India. | 1898 | Noida, Uttar Pradesh, India | USD 26.35 M | 1,192 | ||
Operates an online store specializing in ayurvedic and homeopathic medicines. | 2016 | Delhi, Delhi, India | USD 1.25 M | 16 | ||
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness. | 1992 | Faridabad, Haryana, India | USD 10.08 M | 570 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Krm Ayurveda
Complete news archive for KRM Ayurveda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KRM Ayurveda
KRM Ayurveda was founded in 1937 and raised its 1st funding round 88 years after it was founded.
KRM Ayurveda is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
KRM Ayurveda has 131 employees.
The primary company behind KRM Ayurveda, Krm Ayurveda Limited, reported revenue of ₹102 Cr for FY 2026, up 33% year on year.
KRM Ayurveda, founded in 1937 in Delhi, India, focuses on promoting health and well-being, alternative medicine, consultancy services, and ayurveda and yoga. KRM Ayurveda offers comprehensive consultancy services in yoga, diet, and medications for holistic well-being. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Yes, KRM Ayurveda is publicly traded on NSE under the ticker symbol KRMAYURVED.
KRM Ayurveda has 14 investors. Key investors include Shyam Sunder, Sagar P Brahmbhatt, Nageshwarrao Srikrishna Duvvuri, Amit Jindal, and Saint Capital Fund.
KRM Ayurveda operates through Krm Ayurveda Limited.
The legal entities of KRM Ayurveda currently have 6 directors, including Sanchit Hans, Puneet Dhawan, Tanya Dhawan and others.
